Please login to read the full article.
Scrip Regulatory Affairs
IMI plans "unprecedented" programme for novel antibiotics as drug resistance continues to rise
18 November 2011
Ian Schofield
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- EU parliament resolution plan expected to call for device pre-market authorisation system
- Latest EU patient information plan includes fresh drug safety measures
- French regulatory reform: tough on trials, taxes and transparency
- April brings in new French healthcare laws: update on the implementing rules
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
